Jennifer M. Gogley

FDA investigator

Appears on 8 documents from 2007 to 2019, mostly at sites in California. Most often cites design and construction features (21 CFR 211.42).

8
Documents on file
8.4
Observations per 483
2007
First seen
2019
Most recent

What they cite most

From 67 observations

Activity by year

2007: 1, 2012: 1, 2014: 1, 2015: 2, 2017: 1, 2019: 2

Where

California 7 · South Korea 1

Is Jennifer M. Gogley coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

8 documents, newest first
FirmOpen
483 Huons Co., Ltd.Oct 18, 2019 · Jecheon-si, South Korea
483 McGuff Pharmaceuticals, Inc.Mar 26, 2019 · Santa Ana, California
483 Amphastar Pharmaceuticals, IncMar 31, 2017 · Rancho Cucamonga, California
483 Hartley Medical Center Pharmacy, IncorporatedJul 8, 2015 · Long Beach, California
483 Pyramid Laboratories, Inc.Jan 15, 2015 · Costa Mesa, California
483 South Coast Specialty Compounding, Inc. (Park Pharmacy and Compounding)Jul 2, 2014 · Irvine, California
483 Teva Parenteral Medicines, Inc.Apr 24, 2012 · Irvine, California

About this profile

What does Jennifer M. Gogley inspect?

Jennifer M. Gogley appears on 8 documents on file covering 8 sites, mostly in California.

What do they cite most often?

21 CFR 211.42 (design and construction features), followed by 21 CFR 820.30 and 21 CFR 211.113.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Jennifer M. Gogley is dated Oct 18, 2019.